In recent years, it has had a positive effect when immune checkpoint inhibitors are used in clinical treatment for many types of cancers, with anti-programmed cell death protein 1 (PD-1) inhibitors being one of the leading candidates [7]. Here, PDCD1 is linked to cancer.